Imre Kovesdi

Budapest Business University — Hungary

Biochemistry, Genetics and Molecular Biology · Life Sciences

62h-index12.6kcitations156works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(76), Viral Infectious Diseases and Gene Expression in Insects(32), CAR-T cell therapy research(30), RNA Interference and Gene Delivery(29), Nitric Oxide and Endothelin Effects(18)

Publications156 total

Natural and artificial viral interference in viral diseases
Elsevier eBooks·2025
List of contributors
Elsevier eBooks·2025
Postinfection viral therapy to complement vaccinations against known and emerging viruses
Elsevier eBooks·2025
Breakthrough infection in the presence of neutralizing antibodies by repeated oral administration of viruses
Elsevier eBooks·2025
Infectious bursal disease virus is easy to manufacture and affordable
Elsevier eBooks·2025
Combination of infectious bursal disease virus with ultra-low doses of nivolumab plus ipilimumab could provide functional cure in chronic hepatitis B virus infections
Elsevier eBooks·2025
Combination Therapy for the Treatment of Shingles with an Immunostimulatory Vaccine Virus and Acyclovir
Pharmaceuticals·2023· 8 citedOpen Access
Regression of Human Breast Carcinoma in Nude Mice after Adsflt Gene Therapy Is Mediated by Tumor Vascular Endothelial Cell Apoptosis
Cancers·2022· 2 citedOpen Access
Editorial: Fighting fire with fire: Using non-pathogenic viruses to control unrelated infections
Frontiers in Immunology·2022· 12 citedOpen Access
An Orally Administered Nonpathogenic Attenuated Vaccine Virus Can Be Used to Control SARS-CoV-2 Infection: A Complementary Plan B to COVID-19 Vaccination
Cureus·2022· 8 citedOpen Access
A Clinically Validated, Broadly Active, Oral Viral SuperinfectionTherapy Could Mitigate Symptoms in Early-stage COVID-19 Patients
Infectious Disorders - Drug Targets·2022· 5 cited
Sequential Combination of a Strong Interferon Inducer Viral Vector With Low Doses of Nivolumab Plus Ipilimumab Could Provide Functional Cure in Chronic Hepatitis B Virus infections: Technical Report Proposing a New Modality
Cureus·2022· 9 citedOpen Access
The clinically validated viral superinfection therapy (SIT) platform technology could cure early cases of COVID-19 disease
Preprints.org·2021· 4 citedOpen Access
Regression of Human Breast Carcinoma in Nude Mice After Ad <i>sflt</i> Gene Therapy is Mediated by Tumor Vascular Endothelial Cell Apoptosis
2020Open Access
The Clinically Validated Viral Superinfection Therapy (SIT) Platform Technology May Mitigate Severe Cases of COVID-19 Infections
Preprints.org·2020· 3 citedOpen Access
The Clinically Validated Viral Superinfection Therapy (SIT) Platform Technology May Mitigate Severe Cases of COVID-19 Infections
Preprints.org·2020Open Access
The Clinically Validated Viral Superinfection Therapy (SIT) Platform Technology May Mitigate Severe Cases of 2019-nCoV Infections
Preprints.org·2020· 1 citedOpen Access
Therapeutic Exploitation of Viral Interference
Infectious Disorders - Drug Targets·2019· 23 cited
Post-infection viral superinfection technology could treat HBV and HCV patients with unmet needs
Hepatology Medicine and Policy·2018· 15 citedOpen Access
Effective multiple oral administration of reverse genetics engineered infectious bursal disease virus in mice in the presence of neutralizing antibodies
The Journal of Gene Medicine·2015· 23 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Thomas J. Wickham(15), Alena Lizonová(12), Peter W. Roelvink(7), Ronald R. Reichel(6), Joseph R. Nevins(6), Neil R. Hackett(6), Joseph T. Bruder(5), Douglas E. Brough(4), G M Lee(4), Timothy R. Billiar(4), Ronald G. Crystal(4), Simon C. Watkins(4), Edith Tzeng(4), Edith Tzeng(3), P. W. Roelvink(3), D E Brough(3), Miguel Carrion(3), Ben‐Gary Harvey(3), Melina R. Kibbe(3), R Sethi(3)